{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:54:31Z","timestamp":1788310471708,"version":"build-2803163510"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Japanese encephalitis (JE) is a mosquito-borne infectious disease caused by the Japanese encephalitis virus (JEV), posing a substantial threat to human health and property and safety. Until now, there has been a lack of specific therapeutic options for treating JEV infections. In this review, we provide a comprehensive discussion of JEV\u2019s characteristics, diagnostic methodologies, vaccine development efforts, and potential anti-JEV pharmaceuticals to provide insights that could be used to inform and enhance strategies for the prevention and control of Japanese encephalitis.<\/jats:p>","DOI":"10.4103\/jvbd.jvbd_49_24","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T08:01:29Z","timestamp":1728288089000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Japanese encephalitis virus: An overview"],"prefix":"10.4103","volume":"62","author":[{"given":"Qiuyang","family":"Li","sequence":"first","affiliation":[{"name":"Wuhan Institute of biological products Co., Ltd., Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[{"name":"Wuhan Institute of biological products Co., Ltd., Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[{"name":"Wuhan Institute of biological products Co., Ltd., Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Shi","sequence":"additional","affiliation":[{"name":"Wuhan Institute of biological products Co., Ltd., Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,5]]},"reference":[{"key":"R1-20250307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prevetmed.2018.09.020","article-title":"A quantitative risk assessment (QRA) of the risk of introduction of the Japanese encephalitis virus (JEV) in the United States via infected mosquitoes transported in aircraft and cargo ships","volume":"160","author":"Oliveira","year":"2018","journal-title":"Prev Vet Med"},{"key":"R2-20250307","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.prevetmed.2018.03.018","article-title":"Assessment of data on vector and host competence for Japanese encephalitis virus: A systematic review of the literature","volume":"154","author":"Oliveira","year":"2018","journal-title":"Prev Vet Med"},{"key":"R3-20250307","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jmii.2017.01.005","article-title":"Anti-apoptotic activity of Japanese encephalitis virus NS5 protein in human medulloblastoma cells treated with interferon-\u03b2","volume":"51","author":"Weng","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"R4-20250307","first-page":"491","article-title":"Japanese encephalitis virus","volume":"61","author":"Kurane","year":"2003","journal-title":"Nihon Rinsho"},{"key":"R5-20250307","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2217\/14796708.3.5.515","article-title":"Japanese encephalitis: perspectives and new developments","volume":"3","author":"Saxena","year":"2008","journal-title":"Future Neuro"},{"key":"R6-20250307","doi-asserted-by":"crossref","first-page":"e0124318","DOI":"10.1371\/journal.pone.0124318","article-title":"Profiling of viral proteins expressed from the genomic RNA of Japanese encephalitis virus using a panel of 15 region-specific polyclonal rabbit antisera: implications for viral gene expression","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"R7-20250307","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1128\/JVI.74.9.4244-4252.2000","article-title":"A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice","volume":"74","author":"Chang","year":"2000","journal-title":"J Virol"},{"key":"R8-20250307","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4269\/ajtmh.2007.77.1139","article-title":"Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection","volume":"77","author":"Sapkal","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"R9-20250307","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4269\/ajtmh.2007.77.737","article-title":"Recent change of the antigenicity and genotype of Japanese encephalitis viruses distributed on Okinawa Island, Japan","volume":"77","author":"Saito","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"R10-20250307","first-page":"171","article-title":"Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections","volume":"267","author":"Solomon","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"R11-20250307","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/infdis\/155.3.359","article-title":"The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis","volume":"155","author":"Johnson","year":"1987","journal-title":"J Infect Dis"},{"key":"R12-20250307","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1099\/vir.0.013565-0","article-title":"Glial activation involvement in neuronal death by Japanese encephalitis virus infection","volume":"91","author":"Chen","year":"2010","journal-title":"J Gen Virol"},{"key":"R13-20250307","first-page":"1986","article-title":"West Nile virus meningoencephalitis: MR imaging findings","volume":"26","author":"Petropoulou","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"R14-20250307","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/dc.20410","article-title":"Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo-encephalitis","volume":"34","author":"Rawal","year":"2006","journal-title":"Diagn Cytopathol"},{"key":"R15-20250307","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s002340000396","article-title":"MRI in tick-borne encephalitis","volume":"42","author":"Alkadhi","year":"2000","journal-title":"Neuroradiology"},{"key":"R16-20250307","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/342059","article-title":"Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis","volume":"35","author":"Mickiene","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"R17-20250307","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.ijid.2009.11.020","article-title":"Field evaluation of commercial immunoglobulin M antibody capture ELISA diagnostic tests for the detection of Japanese encephalitis virus infection among encephalitis patients in Nepal","volume":"14","author":"Khalakdina","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R18-20250307","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/00365540802227102","article-title":"Usefulness of RT-PCR for the diagnosis of Japanese encephalitis in clinical samples","volume":"40","author":"Swami","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"R19-20250307","doi-asserted-by":"crossref","first-page":"15533","DOI":"10.1039\/C4CC07888H","article-title":"Aptamer-based biosensors for the rapid visual detection of flu viruses","volume":"50","author":"Le","year":"2014","journal-title":"Chem Commun (Camb)"},{"key":"R20-20250307","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1021\/am5082556","article-title":"Detection of viruses by counting single fluorescent genetically biotinylated reporter immunophage using a lateral flow assay","volume":"7","author":"Kim","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"key":"R21-20250307","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1007\/s11033-010-0525-0","article-title":"Comparison of reverse transcription loop-mediated isothermal amplification, conventional PCR and real-time PCR assays for Japanese encephalitis virus","volume":"38","author":"Chen","year":"2011","journal-title":"Mol Biol Rep"},{"key":"R22-20250307","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jviromet.2007.02.011","article-title":"Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantitation of Japanese encephalitis virus","volume":"143","author":"Santhosh","year":"2007","journal-title":"J Virol Methods"},{"key":"R23-20250307","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1128\/JCM.00582-10","article-title":"Fast duplex one-step reverse transcriptase PCR for rapid differential detection of West Nile and Japanese encephalitis viruses","volume":"48","author":"Yeh","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R24-20250307","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcv.2009.06.010","article-title":"In situ reverse-transcription loopmediated isothermal amplification (in situ RT-LAMP) for detection of Japanese encephalitis viral RNA in host cells","volume":"46","author":"Liu","year":"2009","journal-title":"J Clin Virol"},{"key":"R25-20250307","doi-asserted-by":"crossref","first-page":"113705","DOI":"10.1016\/j.jviromet.2019.113705","article-title":"Development of recombinant nonstructural 1 protein based indirect enzyme linked immunosorbent assay for sero-surveillance of Japanese encephalitis in swine","volume":"272","author":"Dhanze","year":"2019","journal-title":"J Virol Methods"},{"key":"R26-20250307","doi-asserted-by":"crossref","first-page":"120744","DOI":"10.1016\/j.talanta.2020.120744","article-title":"A novel fluorescence molecularly imprinted sensor for Japanese encephalitis virus detection based on metal organic frameworks and passivation-enhanced selectivity","volume":"212","author":"Yang","year":"2020","journal-title":"Talanta"},{"key":"R27-20250307","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biologicals.2019.09.003","article-title":"Evaluation of carboxyl beads based latex agglutination test for rapid sero-diagnosis of Japanese encephalitis","volume":"62","author":"Grace","year":"2019","journal-title":"Biologicals"},{"key":"R28-20250307","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.talanta.2019.04.064","article-title":"Fast and sensitive detection of Japanese encephalitis virus based on a magnetic molecular imprinted polymer-resonance light scattering sensor","volume":"202","author":"Luo","year":"2019","journal-title":"Talanta"},{"key":"R29-20250307","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00508-008-1071-9","article-title":"Japanese encephalitis and vaccines: past and future prospects","volume":"120","author":"Paulke-Korinek","year":"2008","journal-title":"Wien Klin Wochenschr"},{"key":"R30-20250307","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase HI, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"key":"R31-20250307","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1586\/erv.09.112","article-title":"Ixiaro: a new vaccine against Japanese encephalitis","volume":"8","author":"Jelinek","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R32-20250307","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/infdis\/jiz672","article-title":"Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine","volume":"222","author":"Vadrevu","year":"2020","journal-title":"J Infect Dis"},{"key":"R33-20250307","first-page":"334","article-title":"Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China","volume":"81","author":"Ding","year":"2003","journal-title":"Bull World Health Organ"},{"key":"R34-20250307","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.vaccine.2020.01.005","article-title":"A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain)","volume":"38","author":"Yang","year":"2020","journal-title":"Vaccine"},{"key":"R35-20250307","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"R36-20250307","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-35761-6.00033-X","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2018"},{"key":"R37-20250307","first-page":"69","article-title":"Japanese Encephalitis Vaccines: WHO position paper - February 2015","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"R38-20250307","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"key":"R39-20250307","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.vaccine.2019.11.088","article-title":"Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice","volume":"38","author":"Nath","year":"2020","journal-title":"Vaccine"},{"key":"R40-20250307","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cimid.2019.06.008","article-title":"A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines","volume":"65","author":"Slathia","year":"2019","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"R41-20250307","doi-asserted-by":"crossref","first-page":"104106","DOI":"10.1016\/j.meegid.2019.104106","article-title":"Japanese encephalitis virus: A multi-epitope loaded peptide vaccine formulation using reverse vaccinology approach","volume":"78","author":"Chakraborty","year":"2020","journal-title":"Infect Genet Evol"},{"key":"R42-20250307","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/187152611795768051","article-title":"Chemotherapy in Japanese encephalitis: are we there yet?","volume":"11","author":"Dutta","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"R43-20250307","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1517\/14728222.2015.1065817","article-title":"Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges","volume":"19","author":"Ishikawa","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"R44-20250307","doi-asserted-by":"crossref","first-page":"126742","DOI":"10.1016\/j.bmcl.2019.126742","article-title":"Antiviral efficacy of bromo-anilino substituents of 4,5-dihy-drofuran-3-carboxylate compound CW-33 against Japanese encephalitis virus","volume":"29","author":"Lien","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"R45-20250307","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.hermed.2018.10.001","article-title":"Case report on recovery from Japanese encephalitis virus infection by complementary use of phytolacca-mother tincture and in silico analysis","volume":"14","author":"Chaudhury","year":"2018","journal-title":"Journal of Herbal Medicine"},{"key":"R46-20250307","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virusres.2018.06.009","article-title":"Epigallocatechin-3-gallate inhibits the early stages of Japanese encephalitis virus infection","volume":"253","author":"Wang","year":"2018","journal-title":"Virus Res"},{"key":"R47-20250307","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.micpath.2017.11.047","article-title":"Neuroprotective effect of (-)-tetrahydropalmatine in Japanese encephalitis virus strain GP-78 infected mouse model","volume":"114","author":"Lixia","year":"2018","journal-title":"Microb Pathog"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/JVBD.JVBD_49_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:32:40Z","timestamp":1787772760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/JVBD.JVBD_49_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,5]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jvbd.jvbd_49_24","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,5]]},"assertion":[{"value":"2024-03-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}